Sign In
Buy ADCT
$1.15
+0.0600 (+5.50%)
At Close: Jun 23, 2026
ADC Therapeutics SA (ADCT) Stock Jumps 21.8%: Will It Continue to Soar?
09:02am, Friday, 13'th Jan 2023
ADC Therapeutics SA (ADCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
06:19pm, Thursday, 12'th Jan 2023 Benzinga
Gainers
BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity cont
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday
04:59pm, Thursday, 12'th Jan 2023 Benzinga
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording gains in today’s session.
ADC Therapeutics SA (NASDAQ: ADCT) shares jumped 21
4 Analysts Have This to Say About ADC Therapeutics
12:00pm, Wednesday, 04'th Jan 2023 Benzinga
Within the last quarter, ADC Therapeutics (NYSE:ADCT) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
1
2
0
0
Last
Nike, FedEx And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
01:21pm, Wednesday, 21'st Dec 2022 Benzinga
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
ADC Therapeutics SA (NASDAQ: ADCT) shares jumped 36.8% to $4.35 in pr
Why Core Scientific Shares Are Trading Lower By Around 32%; Here Are 26 Stocks Moving Premarket
11:02am, Wednesday, 21'st Dec 2022 Benzinga
Gainers
ADC Therapeutics SA (NASDAQ: ADCT) shares rose 36.8% to $4.35 in pre-market trading. ADC Therapeutics and Sobi announced European Commission approval of ZYNLONTA for the treatment of relapse
Land on 4 Winning Stocks Using the Overlooked Rising P/E Trick
12:01pm, Tuesday, 06'th Dec 2022 Zacks Investment Research
Want to try an out-of-the-box approach? Tap four stocks, namely Eastside Distilling (EAST), AMC Entertainment (AMC), CuriosityStream (CURI) and ADC Therapeutics (ADCT).
Land on 4 Winning Stocks Using the Overlooked Rising P/E Trick
08:17am, Tuesday, 06'th Dec 2022
Want to try an out-of-the-box approach? Tap four stocks, namely Eastside Distilling (EAST), AMC Entertainment (AMC), CuriosityStream (CURI) and ADC Therapeutics (ADCT).
ADC Therapeutics: Running Through A Stretch Of Bad Luck
02:30pm, Tuesday, 29'th Nov 2022
ADCT faced the brunt of the FDA's new policy against rampant accelerated approvals. Despite positive data, Camidanlumab is not going to be in the market anytime soon.
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022
03:05pm, Wednesday, 09'th Nov 2022 Benzinga
Upgrades
Janney Montgomery Scott upgraded the previous rating for First Bancshares Inc (NASDAQ:FBMS) from Neutral to Buy. First Bancshares earned $0.85 in the third quarter, compared to $0.76 in the y
Analyst Ratings for ADC Therapeutics
02:24pm, Wednesday, 09'th Nov 2022 Benzinga
Analysts have provided the following ratings for ADC Therapeutics (NYSE:ADCT) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
1
2
0
0
ADC Therapeutics SA (ADCT) Q3 2022 Earnings Call Transcript
09:19pm, Tuesday, 08'th Nov 2022
ADC Therapeutics SA (NYSE:ADCT ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Amanda Hamilton - IR Manager Ameet Mallik - CEO Joe Camardo - Chief Medical Officer J
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates
01:15pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
ADC Therapeutics SA (ADCT) delivered earnings and revenue surprises of -27.45% and 37.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stoc
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates
09:48am, Tuesday, 08'th Nov 2022
ADC Therapeutics SA (ADCT) delivered earnings and revenue surprises of -27.45% and 37.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stoc
Akoya Biosciences (AKYA) Reports Q3 Loss, Tops Revenue Estimates
10:25pm, Monday, 07'th Nov 2022 Zacks Investment Research
Akoya (AKYA) delivered earnings and revenue surprises of -17.50% and 5.89%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
